Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearchs analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global NSAIDs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of NSAIDs Market byPrudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in NSAIDs Market
Roche
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson and Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
...
Major Type of NSAIDs Covered inPrudent Markets report:
Ibuprofen
Aspirin
Paracetamol
Diclofenac
Others
Application Segments Covered inPrudent Markets Market
Tablets
Capsules
Suspension
Topical Preparations
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global NSAIDs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Ibuprofen -Product Introduction and Major Manufacturers
1.1.2 Aspirin -Product Introduction and Major Manufacturers
1.1.3 Paracetamol -Product Introduction and Major Manufacturers
1.1.4 Diclofenac -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China NSAIDs Status and Prospect (2015-2026)
2.1.1 China NSAIDs Market Size and Growth Rate (2015-2026)
2.1.2 China NSAIDs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU NSAIDs Status and Prospect (2015-2026)
2.2.1 EU NSAIDs Market Size and Growth Rate (2015-2026)
2.2.2 EU NSAIDs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA NSAIDs Status and Prospect (2015-2026)
2.3.1 USA NSAIDs Market Size and Growth Rate (2015-2026)
2.3.2 USA NSAIDs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan NSAIDs Status and Prospect (2015-2026)
2.4.1 Japan NSAIDs Market Size and Growth Rate (2015-2026)
2.4.2 Japan NSAIDs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India NSAIDs Status and Prospect (2015-2026)
2.5.1 India NSAIDs Market Size and Growth Rate (2015-2026)
2.5.2 India NSAIDs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia NSAIDs Status and Prospect (2015-2026)
2.6.1 Southeast Asia NSAIDs Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia NSAIDs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America NSAIDs Status and Prospect (2015-2026)
2.7.1 South America NSAIDs Market Size and Growth Rate (2015-2026)
2.7.2 South America NSAIDs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 NSAIDs Status and Prospect (2015-2026)
2.8.1 NSAIDs Market Size and Growth Rate (2015-2026)
2.8.2 NSAIDs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global NSAIDs Market Assessment by Segment
3.1 Global NSAIDs Capacity and Growth Rate
3.2 Global NSAIDs Sales by Type
3.3 Global NSAIDs Sales Revenue by Type
3.4 Global NSAIDs Consumption by Application
4 Global NSAIDs Market Assessment by Regions
4.1 Global NSAIDs Production Analysis and Forecast by Regions (2015-2026)
4.2 Global NSAIDs Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global NSAIDs Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 NSAIDs Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on NSAIDs Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global NSAIDs Capacity Market Share of Manufacturers (2019-2020)
6.2 Global NSAIDs Sales Market Share of Manufacturers (2019-2020)
6.3 Global NSAIDs Sales Revenue Market Share of Manufacturers (2019-2020)
7 NSAIDs Competitive Analysis
7.1 Roche
7.1.1 Roche Company Profiles
7.1.2 Roche Product Introduction
7.1.3 Roche NSAIDs Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Amgen
7.2.1 Amgen Company Profiles
7.2.2 Amgen Product Introduction
7.2.3 Amgen NSAIDs Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 B-MS
7.3.1 B-MS Company Profiles
7.3.2 B-MS Product Introduction
7.3.3 B-MS NSAIDs Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Merck
7.4.1 Merck Company Profiles
7.4.2 Merck Product Introduction
7.4.3 Merck NSAIDs Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Pfizer
7.5.1 Pfizer Company Profiles
7.5.2 Pfizer Product Introduction
7.5.3 Pfizer NSAIDs Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Novartis
7.6.1 Novartis Company Profiles
7.6.2 Novartis Product Introduction
7.6.3 Novartis NSAIDs Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Company Profiles
7.7.2 Eli Lilly and Company Product Introduction
7.7.3 Eli Lilly and Company NSAIDs Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Company Profiles
7.8.2 Johnson and Johnson Product Introduction
7.8.3 Johnson and Johnson NSAIDs Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 GSK
7.9.1 GSK Company Profiles
7.9.2 GSK Product Introduction
7.9.3 GSK NSAIDs Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Sanofi
7.10.1 Sanofi Company Profiles
7.10.2 Sanofi Product Introduction
7.10.3 Sanofi NSAIDs Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Boehringer Ingelheim
7.12 Zhejiang Jiuzhou Pharmaceutical
8 Conclusion